Genetic Analysis of Afibrinogenemia and Hypofibrinogenemia: Novel Mutations in the <i>FGB</i> Gene in the Turkish Population

dc.authorscopusid57195415079
dc.authorscopusid6603904911
dc.authorscopusid7102515965
dc.authorwosidÖZKAN, Didem Torun/AAB-3081-2021
dc.contributor.authorOzkan, Didem Torun
dc.contributor.authorSarper, Nazan
dc.contributor.authorAkar, Nejat
dc.contributor.otherTıbbi Laboratuvar Teknikleri / Medical Laboratory Techniques
dc.date.accessioned2024-05-25T12:30:20Z
dc.date.available2024-05-25T12:30:20Z
dc.date.issued2020
dc.departmentOkan Universityen_US
dc.department-temp[Ozkan, Didem Torun] Istanbul Okan Univ, Vocat Sch Hlth Serv, Tuzla Campus, TR-34900 Istanbul, Turkey; [Sarper, Nazan] Kocaeli Univ, Sch Med, Pediat Hematol Dept, Kocaeli, Turkey; [Akar, Nejat] TOBB Econ & Tech Univ Hosp, Pediat Dept, Ankara, Turkeyen_US
dc.description.abstractIntroduction: Congenital afibrinogenemia is a rare autosomal recessive disorder characterized by bleeding that varies from mild to severe and by complete absence or extremely low levels of plasma and platelet fibrinogen. Hypofibrinogenemia is characterized by fibrinogen levels Objective: In this study, we analyzed fibrinogen beta chain gene mutations in Turkish afibrinogenemia and hypofibrinogenemia patients. Methods: We evaluated 20 afibrinogenemia and hypofibrinogenemia patients and 80 healthy controls. We have sequenced all exons of the FGB gene using the DNA isolated from the peripheral blood samples of patients and controls. Results and Conclusion: We found a nonsense mutation in exon 4 at nucleotide 630 that encoded serine amino acid, and in the same exon a missense mutation of T to C at nucleotide 647, resulting in a transition from leucine to proline (p.L198P) in a child with hypofibrinogenemia. These mutations have been shown for the first time in the same patient of Turkish descent. Furthermore, there was a novel heterozygous guanine-to-adenine nucleotide change in exon 3. This caused the change of arginine amino acid to threonine amino acid at position 136 (p.A136T) in a protein, which has not been described in the literature before.en_US
dc.identifier.citation1
dc.identifier.doi10.1159/000505174
dc.identifier.endpage532en_US
dc.identifier.issn0001-5792
dc.identifier.issn1421-9662
dc.identifier.issue6en_US
dc.identifier.pmid32289806
dc.identifier.scopus2-s2.0-85083660570
dc.identifier.scopusqualityQ2
dc.identifier.startpage529en_US
dc.identifier.urihttps://doi.org/10.1159/000505174
dc.identifier.urihttps://hdl.handle.net/20.500.14517/2196
dc.identifier.volume143en_US
dc.identifier.wosWOS:000595190700005
dc.identifier.wosqualityQ3
dc.institutionauthorÖzkan, Didem
dc.language.isoen
dc.publisherKargeren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCongenital afibrinogenemiaen_US
dc.subjectHypofibrinogenemiaen_US
dc.subjectFibrinogen beta chain gene mutationsen_US
dc.titleGenetic Analysis of Afibrinogenemia and Hypofibrinogenemia: Novel Mutations in the <i>FGB</i> Gene in the Turkish Populationen_US
dc.typeArticleen_US
dspace.entity.typePublication
relation.isAuthorOfPublicatione13f2c86-e39b-4589-b1de-9df06dc529d5
relation.isAuthorOfPublication.latestForDiscoverye13f2c86-e39b-4589-b1de-9df06dc529d5
relation.isOrgUnitOfPublicatione15c4d51-8b3d-4d87-9a58-8a8f20fff42b
relation.isOrgUnitOfPublication.latestForDiscoverye15c4d51-8b3d-4d87-9a58-8a8f20fff42b

Files